Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00708604 · ClinicalTrials.gov registry record · Phase 1
Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes
A Phase 1 study, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT00708604: Completed Phase 1 study, sponsored by City of Hope Medical Center.
NCT00708604 is a Phase 1 study that has completed, run by City of Hope Medical Center. The registered enrollment target is 3 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00708604, a Phase 1 study, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety of islet transplantation in patients with type 1 diabetes who have had a successful kidney transplant and have been maintained for at least three months on anti-rejection medications consisting of any combination of sirolimus, tacrolimus, MMF or prednisone (5 mg/day or less). Another purpose is to determine the effectiveness of an islet transplant in inducing insulin independence and whether or not an islet transplant improves quality of life for kidney transplants patients with type 1 diabetes.
Interventions
- BIOLOGICAL Islet cell transplantation
- PROCEDURE Islet Transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2008-10-18 |
| Est. Completion | 2014-06 |
| Phase | Phase 1 |
What the finished NCT00708604 record still lists
NCT00708604 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Islet cell transplantation is the first listed.
NCT00708604 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00708604 about?
NCT00708604 is a clinical study titled "Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes". The purpose of this study is to determine the safety of islet transplantation in patients with type 1 diabetes who have had a successful kidney transplant and have been maintained for at least three months on anti-rejection medications consisting of any combination of sirolimus, tacrolimus, MMF or p...
What is the current status of trial NCT00708604?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2008-10-18. Estimated completion is 2014-06.
What interventions are being tested in trial NCT00708604?
The interventions under investigation include: Islet cell transplantation (BIOLOGICAL), Islet Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT00708604?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00708604's enrollment target sits among peer trials
3 1999th of 2000 higher than 1 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI